Fred Hutchinson Cancer Center is at the forefront of a fundamental shift in how cancer is treated and cured. At Fred Hutch, PICI researcher Philip Greenberg, MD, develops new ways to empower a patient’s immune system to eradicate cancer. With PICI, he uses mouse models to characterize and test translatable strategies to treat many cancers. He also develops more effective T-cells to treat ovarian cancer through adoptive cell therapy. Tijana Martinov, PhD, a Parker Scholar in Greenberg’s lab, designs and tests T-cells that target and destroy multiple myeloma in mouse models. Philip Greenberg, MD | Investigator Tijana Martinov, PhD | Parker Scholar Related Research Focus CAR-T and Cell Therapy: The Next Wave Announcement, Cancer Research Heroes PICI Celebrates Carl H. June, MD Announcement, Our Impact PICI Network Researchers at SITC Spring Scientific Announcement, Cancer Research Heroes PICI Honors CAR T-cell Pioneer Carl H. June, MD Announcement, Our Impact PICI Network Researchers at #KSCancerImmuno23 Announcement PICI Network Presenters at #KScelltherapy23 Our Impact 2022 Year in Review Announcement PICI Network Researchers to Present at #ASH22 Announcement PICI Network Researchers to Present at #SITC22